Clinical Trial Update: Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating serlopitant for pruritus in plaque psoriasis has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pruritus
• Psoriasis

Drugs mentioned

• Serlopitant (serlopitant)

Snippet

Sponsor: Vyne Therapeutics Inc. | Conditions: Pruritus, Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2019-06-12